Yeast-derived vacuoles as potential therapeutic agents for modulating neuroinflammation in Alzheimer's disease
{{output}}
Neuroinflammation is a major contributor to Alzheimer's disease (AD) pathology, including amyloid precursor protein (APP)/amyloid-beta (Aβ)-associated protein expression and Tau phosphorylation. Here, we evaluated yeast-derived vacuoles as orally deliverable... ...
